PNC Financial Services Group’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $264 | Sell |
36
-105
| -74% | -$770 | ﹤0.01% | 4776 |
|
|
2025
Q1 | $1.22K | Buy |
141
+133
| +1,663% | +$1.15K | ﹤0.01% | 4485 |
|
|
2024
Q4 | $286 | Hold |
8
| – | – | ﹤0.01% | 4605 |
|
|
2024
Q3 | $378 | Hold |
8
| – | – | ﹤0.01% | 4602 |
|
|
2024
Q2 | $402 | Hold |
8
| – | – | ﹤0.01% | 4559 |
|
|
2024
Q1 | $896 | Hold |
8
| – | – | ﹤0.01% | 4384 |
|
|
2023
Q4 | $464 | Buy |
+8
| New | +$464 | ﹤0.01% | 4425 |
|
|
2022
Q1 | – | Sell |
-19
| Closed | -$3K | – | 4642 |
|
|
2021
Q4 | $3K | Hold |
19
| – | – | ﹤0.01% | 4082 |
|
|
2021
Q3 | $5K | Sell |
19
-506
| -96% | -$133K | ﹤0.01% | 3942 |
|
|
2021
Q2 | $178K | Sell |
525
-84
| -14% | -$28.5K | ﹤0.01% | 2295 |
|
|
2021
Q1 | $246K | Buy |
609
+361
| +146% | +$146K | ﹤0.01% | 2044 |
|
|
2020
Q4 | $165K | Buy |
248
+229
| +1,205% | +$152K | ﹤0.01% | 2182 |
|
|
2020
Q3 | $9K | Hold |
19
| – | – | ﹤0.01% | 3541 |
|
|
2020
Q2 | $11K | Buy |
+19
| New | +$11K | ﹤0.01% | 3441 |
|